NCT05703074View on ClinicalTrials.gov

Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

September 23, 2024

Study Completion Date

July 31, 2025

Conditions
Long COVID
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside (NR)

4 capsules (a total of 1000 mg) 2 times daily for 84 days

BEHAVIORAL

Mind-body reprocessing therapy (MBRT)

4-6 face-to-face meetings over 3-4 weeks, unlimited access to designated online resources.

BEHAVIORAL

Care as usual

A brief self-help leaflet on long COVID is distributed, otherwise care as usual by the general practitioner

DIETARY_SUPPLEMENT

Placebo

4 capsules (empty) 2 times daily for 84 days.

Trial Locations (1)

1478

Akershus University Hospital, Lørenskog

All Listed Sponsors
lead

University Hospital, Akershus

OTHER